First Tracks Biotherapeutics, Inc. (TRAX)
30.63
-0.76
(-2.42%)
USD |
NASDAQ |
Oct 07, 15:37
First Tracks Biotherapeutics Price to Book Value : 6.422 for Oct. 7, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 6.581 |
| October 05, 2026 | 6.917 |
| October 02, 2026 | 6.978 |
| October 01, 2026 | 7.112 |
| September 30, 2026 | 7.431 |
| September 29, 2026 | 7.544 |
| September 28, 2026 | 7.683 |
| September 25, 2026 | 7.217 |
| September 24, 2026 | 7.512 |
| September 23, 2026 | 7.686 |
| September 22, 2026 | 8.603 |
| September 21, 2026 | 8.175 |
| September 18, 2026 | 8.093 |
| September 17, 2026 | 8.219 |
| September 16, 2026 | 8.177 |
| September 15, 2026 | 8.066 |
| September 14, 2026 | 7.877 |
| September 11, 2026 | 7.640 |
| September 10, 2026 | 7.963 |
| September 09, 2026 | 8.296 |
| September 08, 2026 | 8.764 |
| September 04, 2026 | 8.483 |
| September 03, 2026 | 8.913 |
| September 02, 2026 | 9.494 |
| September 01, 2026 | 8.632 |
| Date | Value |
|---|---|
| August 31, 2026 | 8.772 |
| August 28, 2026 | 8.777 |
| August 27, 2026 | 9.380 |
| August 26, 2026 | 9.265 |
| August 25, 2026 | 9.458 |
| August 24, 2026 | 9.074 |
| August 21, 2026 | 9.039 |
| August 20, 2026 | 8.785 |
| August 19, 2026 | 9.540 |
| August 18, 2026 | 9.200 |
| August 17, 2026 | 9.141 |
| August 14, 2026 | 9.234 |
| August 13, 2026 | 9.232 |
| August 12, 2026 | 9.672 |
| August 11, 2026 | 9.802 |
| August 10, 2026 | 10.05 |
| August 07, 2026 | 9.504 |
| August 06, 2026 | 9.50 |
| August 05, 2026 | 9.844 |
| August 04, 2026 | 9.647 |
| August 03, 2026 | 9.678 |
| July 31, 2026 | 9.234 |
| July 30, 2026 | 10.02 |
| July 29, 2026 | 8.779 |
| July 28, 2026 | 8.774 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Forte Biosciences, Inc. | 8.580 |
| AnaptysBio, Inc. | 128.97 |
| Immunovant, Inc. | 8.995 |
| ACADIA Pharmaceuticals, Inc. | 2.568 |
| Agenus, Inc. | -- |
Price to Book Value Related Metrics
| Price | 30.63 |
| Earnings Yield | -16.13% |
| Market Cap | 1.084B |